From a chemical therapeutics standpoint, Relafen 750 ( Naproxen Sodium ) presents a fascinating case study in therapeutic action. Its mechanism of effect primarily involves the blockade of cyclooxygenase (COX ) enzymes, particularly COX-2 , leading to a diminution in the synthesis of inflammatory